ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TNYA Tenaya Therapeutics Inc

4.265
-0.035 (-0.81%)
Last Updated: 13:02:37
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Tenaya Therapeutics Inc TNYA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.035 -0.81% 4.265 13:02:37
Open Price Low Price High Price Close Price Prev Close
4.29 4.14 4.40 4.30
more quote information »

Recent News

Date Time Source Heading
3/18/202416:05GLOBETenaya Therapeutics Reports Fourth Quarter and Full Year..
3/18/202408:30GLOBETenaya Therapeutics Announces Publication of TN-401 Gene..
2/27/202419:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202416:30GLOBETenaya Therapeutics to Participate in Upcoming March..
2/26/202408:30GLOBETenaya Therapeutics Announces Publication of Preclinical..
2/16/202420:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202420:13EDGAR2Form 144 - Report of proposed sale of securities
2/08/202417:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/08/202408:15EDGAR2Form 8-K - Current report
2/08/202408:00GLOBETenaya Therapeutics Announces Pricing of Underwritten..
1/31/202416:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
1/03/202408:30GLOBETenaya Therapeutics to Participate at the 42nd Annual J.P...
11/21/202316:30GLOBETenaya Therapeutics to Participate at the 35th Annual Piper..
11/08/202316:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202316:12EDGAR2Form 8-K - Current report
11/08/202316:05GLOBETenaya Therapeutics Reports Third Quarter 2023 Financial..
10/26/202308:30GLOBETenaya Therapeutics Announces FDA Clearance to Begin..
10/09/202308:30GLOBETenaya Therapeutics Presents Encouraging New Clinical and..
10/05/202308:30GLOBETenaya Therapeutics Doses First Patient in the MyPeak-1™..
10/02/202317:30GLOBETenaya Therapeutics Publishes Preclinical Data in..
9/21/202316:05GLOBETenaya Therapeutics to Present Data for TN-301 and TN-201 at..
8/31/202316:05GLOBETenaya Therapeutics to Participate at the 21st Annual Morgan..
8/18/202318:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/16/202321:10EDGAR2Form 144 - Report of proposed sale of securities
8/09/202316:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/202316:19EDGAR2Form 8-K - Current report
8/09/202316:05GLOBETenaya Therapeutics Reports Second Quarter 2023 Financial..
8/02/202316:05GLOBETenaya Therapeutics to Participate at the 43rd Annual..
5/10/202316:19GLOBETenaya Therapeutics Reports First Quarter 2023 Financial..
5/03/202308:00GLOBETenaya Highlights Growing Capabilities in AAV Manufacturing,..
5/02/202308:43DJNTenaya Therapeutics Gets FDA Fast-Track Designation for..
5/02/202307:50GLOBETenaya Therapeutics Receives FDA Fast Track Designation for..
4/21/202316:05GLOBETenaya Therapeutics to Participate at Chardan's 7th Annual..

Your Recent History

Delayed Upgrade Clock